# A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia

> **NCT04435431** · PHASE2 · COMPLETED · sponsor: **Integrative Research Laboratories AB** · enrollment: 155 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Mesdopetam
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04435431
- **Lead sponsor:** Integrative Research Laboratories AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-29
- **Primary completion:** 2022-12-02
- **Final completion:** 2022-12-09
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2024-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04435431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04435431, "A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04435431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*